Knowles DM: Neoplastic Hematopathology, 3rd Addition

Salemi A, Agrawal YP: An assay to monitor bivalirudin levels in cardiopulmonary bypass. Ann Thoracic Surg 92:332-4, 2011.

Carmel R, Agrawal YP: Failures of cobalamin assays in pernicious anemia. New Engl J Med 367:385-386, 2012.

Agrawal YP, Rennert H: Pharmacogenomic testing of toxicological drugs. Clin Lab Med 32:509-523, 2012.

Solomon AB, Beneck D: Tracheobronchial remnants: a rare congenital anomaly. Clin Gastroenterol Hepatol 9:A26, 2011.

Altorki NK, Christos P, Port JL, Lee PC, Mirza F, Spinelli C, Keresztes R, Beneck D, Paul S, Stiles BM, Zhang Y, Schrump DS: Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial. J Thorac Oncol 6:1121-1127, 2011.

Heller DS, Goldsmith LT, Aboujaoude R, Kaplan C, Baergen R, Cole D: Collagen expression in the pregnant human cervix Is decreased with labor. J Lower Gen Tract Disease 16: 4-9, 2012.

Maloney K, Baergen RN: Types of maternal hypertensive disease and their association with pathologic lesions and clinical factors. Fetal Pediatr Pathol 31:319-23, 2012.

Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, Lu KH, Sood AK, Birrer MJ, Ozols R, Baergen R, Emerson R, Steinhoff M, Behmaram B, Rasty G, Gershenson DM: Reclassification of serous carcinoma of the ovary using a two-tier grading system: A Gynecologic Oncology Group Study. Cancer 18:3087-94, 2012.

Jain S, Ward MM, O'Loughlin J, Boeck M, Wiener N, Chuang E, Cigler T, Moore A, Donovan D, Lam C, Cobham MV, Schneider S, Christos P, Baergen RN, Swistel A, Lane ME, Mittal V, Rafii S, Vahdat LT: Incremental increase in VEGFR1(+) hematopoietic progenitor cells and VEGFR2(+) endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. Breast Cancer Res Treat 132:235-4, 2012.

Gurian MS, Kovanlikaya A, Beneck D, Baron KT, John M, Brill PW: Radiologic-pathologic correlation in acute appendicitis: can we use it as a quality measure to assess interpretive accuracy of radiologists? Clin Imag 35: 421-423, 2011.

E Cheng, L Cohen, S Gasinu, C Sy, Beneck D, Spigland N: Cecal diverticulitis as a continuing diagnostic and management dilemma: a report of two cases in children. Pediatr Surg Int 28:99-102, 2012.

Chen YT, Chiu R, Lee P, Beneck D, Boquan J, Old LJ: Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma. Hum Reprod 26: 3232-3243, 2011.

Bretz J, Garcia J, Huang X, Kang L, Zhang Y, Toellner KM, Chen-Kiang S: Noxa mediates p18ink4c cell cycle control of homeostatsis in B cells and plasma cell precursors. Blood 117: 2179-2188, 2011.

Huang X, Di Liberto M, Jayabalan D, Liang J, Ely S, Bretz J, Shaffer III AL, Louie T, Che, I, Randolph S, Hahn WC, Staudt LM, Niesvizky R, Moore MAS, Chen-Kiang S: Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4. Blood 120:1095-106, 2012.

Leonard JP, LaCasce AS, Smith MR, Noy A, Chirieac LR, Rodig SJ, Yu JQ, Vallabhajosula S, Schoder H, English P, Neuberg DS, Martin P, Millenson MM, Ely SA, Courtney R, Shaik N, Wilner KD, Randolph S, Van den Abbeele AD, Chen-Kiang SY, Yap JT, Shapiro GI: Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood 119: 4597- 4607, 2012.

Nardiello T, Jungbluth AA, Mei A, Di Liberto M, Huang X, Dabrowski A, Andrade V, Wasserstrum R, Ely S, Niesvizky R, Pearse R, Coleman M, Jayabalan DS, Bhardwaj N, Old LJ, Chen-Kiang S, Cho HJ: MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of surviving. Clin Ca Res 17: 4309-4319, 2011.

Torres R, Genzen JR, Levene MJ: Clinical measurement of von Willebrand factor by fluorescence correlation spectroscopy. Clin Chem 58:1010-8, 2012.

Genzen JR, Motin A: Cholesterol crystals in pleural fluid. Am J Respir Crit Care Med 185:586, 2012.

Genzen JR: An 83 year old female with discordant urine protein results. Clin Chem 57: 1779-1780, 2011.

Genzen JR, Kawaguchi KR, Furman RR: Detection of a monoclonal antibody therapy (ofatumumab) by serum protein and immunofixation electrophoresis (IFE). Brit J Haematol 123-5, 2011.

Genzen JR, Tormey CA: Pathology consultation on reporting of critical values. Am J Clin Pathol 135: 505-13, 2011.

Geyer JT, Verma S, Mathew S, Wang YL, Racchumi J, Espinal-Witter R, Subramaniyam S, Knowles DM, Orazi A: Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q). Hum Pathol Sep 17 [Epub ahead of print], 2012.

Geyer JT, Deshpande V: IgG4-associated sialadenitis. Curr Opin Rheumatol 23:95-101, 2011.

Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE: Phase II AIDS malignancy consortium trial of topical halofuginone in AIDS-related Kaposi’s sarcoma. J Acquir Immune Defic Syndr 56:64-8, 2011.

Barsam SJ, Psaila B, Sloane PA, Page LK, Forestier M, Geyer JT, Villarica GO, Ruisi MM, Gernsheimer TB, Beer JH, Bussel JB: Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia (ITP). Blood 117:5723-32, 2011.

Ghanima W, Junker P, Hasselbalch HC, Boiocchi L, Geyer JT, Feng X, Gudlbrandsdottir S, Orazi A, Bussel JB: Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents. Br J Haematol 155:248-55, 2011.

Wilson SR, Leonard JP, Geyer JT, Osborn JR, Weinsaft JW: A worrisome interventricular septum: more than meets the eye. J Am Coll Cardiol 58:e43, 2011.

Boiocchi L, Espinal-Witter R, Geyer JT, Steinhilber J, Bonzheim I, Knowles DM, Fend F, Orazi A: Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease. Mod Pathol Epub ahead of print, 2012.

Upmacis RK, Shen H, Benguigui LES, Lamon BD, Deeb RS, Hajjar KA, Hajjar DP: Inducible nitric oxide synthase provides protection against injury-induced thrombosis. Am J Physiol 301: H617-624, 2011.

Duan Y, Chen Y, Hu W, Li X, X Zhou X, Kong D, Hajjar DP, Han J: PPARγ activation by ligands and dephosphorylation induces PCSK9 and LDL receptor expression. J Biol Chem 287:23667-23677, 2012.

Kato MA, Buitrago D, Moo TA, Keutgen XM, Hoda RS, Ricci JA, Christos PJ, Yang G, Fahey TJ 3rd, Zarnegar R: Predictive value of cytologic atypia in indeterminate thyroid fine-needle aspirate biopsies. Ann Surg Oncol 18:2893-8, 2011.

Kaplan R, Hoda SA, Hoda RS: Cytological evaluation of bloody nipple discharge fluid. Diagn Cytopathol Nov 1 [Epub], 2011.

Buitrago D, Keutgen XM, Crowley M, Filicori F, Aldailami H, Hoda R, Liu YF, Hoda RS, et al: Intercellular Adhesion Molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma. Ann Surg Oncol 9:973-80, 2012.

Baird JS, Buet A, Hymes SR, Ravindranath TM, Zackai S, Cannon J-M, Messina M, Sury J, Green R, Della-Latta P, Jenkins SG, Greenwald BM, Furuya EY, Graham PL, Sonnett FM, Platt S, DeLaMora P, Saiman L: Comparing the clinical severity of the first versus second wave of 2009 Influenza A(H1N1) in a New York City pediatric healthcare facility. Ped Crit Care Med 13:375-380, 2012.

Satlin MJ, Calfee DP, Chen L, Fauntleroy KA, Wilson SJ, Jenkins SG, Feldman EJ, Roboz GJ, Shore TB, Helfgott DC, Soave R, Kreiswirth BN, Walsh TJ: Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymph Aug 23. [Epub ahead of print], 2012.

Weisenberg SA, Mediavilla JR, Chen L, Alexander EA, Rhee KY, Kreiswirth BN, Jenkins SG: Extended spectrum beta-lactamase-producing enterobacteriaceae in international travelers and non-travelers in New York City. PloS One. 7:e45141, 2012.

Pastagia M, Kleinman LC, Lacerda de la Cruz EG, Jenkins SG: Calculating the risk of mortality due to methicillin-resistant Staphylococcus aureus bacteremia using vancomycin minimum inhibitory concentration, Heteroresistance and patient correlates. Emerg Infect Dis 15:1072-1080, 2012.

Chen L, Chavda KD, Mediavilla JR, Zhao Y, Fraimow HS, Jenkins SG, Levi MH, Hong T, Rojtman AD, Ginocchio CC, Bonomo RA, Kreiswirth BN: Multiplex Real-time PCR for Detection of Epidemic KPC-producing Klebsiella pneumoniae ST258. Antimicrobial Agents Chemo 56:3444-3447, 2012.

Jenkins SG, Schuetz AN: Laboratory testing to guide antimicrobial therapy. Mayo Clin Proceed 87:290-308, 2012.

Satlin MJ, Kubin CJ, Blumenthal JS, Cohen AB, Furuya EY, Wilson SJ, Jenkins SG, Calfee DP: Comparative Effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from the urine. Antimicrob Agents Chemo 55:5893-5899, 2011.

Jenkins SG, Jerris RC: Critical Assessment of Issues Applicable to Development of Antimicrobial Susceptibility Testing Breakpoints. J Clin Microbiol 49:S5-S10, 2011.

Bossler A, Gunsolly C, Pyne MT, Rendo A, Rachel J, Mills R, Miller M, Sipley J, Hillyard D,Jenkins S, Essmyer C, Young S, Lewinski M, Satlin MJ, Kubin CJ, Blumenthal JS,Rennert H: Performance of the COBAS® AmpliPrep/COBAS TaqMan® automated system for hepatitis C virus (HCV) quantification in a multi-center comparison. J Clin Virol 50:100-3, 2011.

Jenkins SG, Raskoshina L, Schuetz AN: Comparative performance of a novel chromogenic spectra VRE agar to bile esculin azide and Campylobacter agars for the detection of vancomycin-resistant enterococci in fecal samples. J Clin Microbiol 49:3947-3949, 2011.

Patel G, Jenkins SG, Mediavilla JR, Kreiswirth BN, Radbill B, Salgado CD, Calfee DP: Clinical and molecular epidemiology of methicillin-resistant staphylococcus aureus among patients in an ambulatory hemodialysis center. Infect Control Epidemiol 32:881-888, 2011.

Ho VP , Jenkins SG, Afaneh CI, Turbendian HK, Nicolau DP, Barie PS: Use of meropenem by continuous infusion to treat a Bla(kpc-2)-positive Klebsiella pneumoniae blood stream infection. Surg Infect 12:325-327, 2011.

Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, et al: A. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 13:170–180, 2011.

Nuovo GJ, Hagood JS, Magro CM, Chin N, Kapil R, Davis L, Marsh CB, Folcik VA: The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis. Mod Pathol 25:416-33, 2012.

Minkis K, Aksentijevich I, Goldbach-Mansky R, Magro C, Scott R, Davis JG, Sardana N, Herzog R: Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile Pustular Psoriasis. Arch Dermatol 148:747-52, 2012.

Summe HS, Greenlaw SM, Deng A, Magro C, Wiss K: Generalized Spinous Follicular Lichen Nitidus with Perifollicular Granulomas. Pediatr Dermatol. Jul 8, 2012.

Gable AD, Clark SH, Magro CM: Myxoid variant of anaplastic large cell lymphoma involving the skin: a case report. J Cutan Pathol 39:787-90, 2012.

Magro CM, Wang X: Indolent primary cutaneous γ/δ T-Cell lymphoma localized to the subcutaneous panniculus and its association with atypical lymphocytic lobular panniculitis. Am J Clin Pathol 138:50-6, 2012.

Chapin J, Weksler B, Magro C, Laurence J: Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura. Br J Haematol 157:772-4, 2012.

Pinto A, McLaren SH, Poppas DP, Magro CM: Genital melanocytic nevus arising in a background of lichen sclerosus in a 7-year-old female: The diagnostic pitfall with malignant melanoma. A Literature Review. Am J Dermatopathol Jun 12, 2012.

Furer V, Franks A, Magro C, Samuels J: Musculoskeletal ultrasound prompts a rare diagnosis of Mycobacterium marinum infection. Scand J Rheumatol 41:316-8, 2012.

Magro CM, Yang SE, Zippin JH, Zembowicz A: Expression of soluble adenylyl cyclase in lentigo maligna. Arch Pathol Lab Med Jul 24, 2012.

Shumway BS, Rawal YB, Allen CM, Kalmar JR, Magro CM: Oral Atypical Cellular Blue Nevus: An Infiltrative Melanocytic Proliferation. Head Neck Pathol. 2012 Aug 1.

Camp BJ, Magro CM: Cutaneous macroglobulinosis: a case series. J Cutan Pathol. 2012 Jul 18;9999(9999).

Chaser BE, Renszel KM, Crowson AN, Osmundson A, Shendrik IV, Yob EH, Drew GS, Callegari PR, Campbell S, Pitha JV, Magro CM. Onycholemmal carcinoma: A morphologic comparison of 6 reported cases. J Am Acad Dermatol. 2012 Aug 20.

Sagransky MJ, Deng AC, Magro CM. Primary Cutaneous Langerhans Cell Sarcoma: A report of Four Cases and Review of the Literature. Am J Dermatopathol. 2012 Oct 9.

Wang X, Magro CM. Human Myxovirus Resistance Protein 1 (MxA) as a useful marker in the differential diagnosis of subcutaneous lymphoma vs. lupus erythematosus profundus. Eur J Dermatol. 2012 Oct 2.

Magro CM, Roberts-Barnes J, Crowson AN. Direct immunofluorescence testing in the diagnosis of immunobullous disease, collagen vascular disease, and vascular injury syndromes. Dermatol Clin. 2012 Oct;30(4):763- 98.

Hagen JW, Magro CM, Crowson AN. Emerging adverse cutaneous drug reactions. Dermatol Clin. 2012 Oct;30(4):695-730.

Brandt JS, Fishman S, Magro CM. Cutaneous melanoma arising from a cesarean delivery skin scar. J Perinatol. 2012 Oct;32(10):807-9.

Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E: A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood 117:4852-4854, 2011.

Green TM, Young KH, Visco C, Xu-Monette ZY, Orazi A, Go RS, Nielsen O, Gadeberg OV, Mourits-Andersen T, Frederiksen M, Pedersen LM, Møller MB: Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large b-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, Vincristine, and prednisone. J Clin Oncol 30:3460-7, 2012.

Xu-Monette ZY, Wu L, Visco C, Tai YC, Tzankov A, Liu WM, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, et al: Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: a report from an International DLBCL Rituximab-CHOP Consortium Program study. Blood Sep 5 [Epub ahead of print], 2012.

Thiele J, Orazi A, Kvasnicka HM, Franco V, Boveri E, Gianelli U, Gisslinger H, Passamonti F, Tefferi A, Barbui T: European bone marrow working group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 97:e5-6; discussion e7-8, 2012.

Tripodo C, Sangaletti S, Guarnotta C, Piccaluga PP, Cacciatore M, Giuliano M, Franco G, Chiodoni C, Sciandra M, Miotti S, Calvaruso G, Vetri V, Carè A, Florena AM, Scotlandi K, Orazi A, Pileri SA, Colombo MP: Stromal SPARC Contributes to the detrimental fibrotic changes associated with myeloproliferation while its deficiency favors myeloid cell expansion. Blood Sep 5 [Epub ahead of print], 2012.

Zhou J, Czader M, Orazi A: Myelodysplastic syndromes. Sem Diagn Pathol 28:258-72, 2011.

Chiu A, Orazi A: Mastocytosis and mastocytic overlap syndromes. Sem Diagn Pathol 29:19-30, 2012.

Czader M, Orazi A: World Health Organization classification of myelodysplastic syndromes. Curr Pharm Des 18:3149-62, 2012.

Boiocchi L, Arabadjief M, Ghanima W, Bussel JB, Orazi A, Geyer JT: Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities. Mod Pathol 25:65-74, 2012.

Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, Tai YC, Li Y, Liu WM, d'Amore ES, Li Y, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, et al: Patients with diffuse large B cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP consortium program study. Haematologica Aug 28. [Epub ahead of print], 2012.

Panarelli NC, Sela R, Schreiner AS, Crapanzano JP, Klimstra DS, Schnoll-Sussman F, Pochapin MB, Yantiss RK: Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions. Am J Surg Pathol 36:1434-43, 2012.

Panarelli NC, Yantiss RK, Yeh M, Chen YT: Tissue-specific Cadherin CDH17 is a useful marker of adenocarcinomas arising from the gastrointestinal tract: A comparison with CDX2. Am J Clin Pathol 138:211-222, 2012.

Panarelli NC, Zhou XK, Kitabayashi N, Chen YT, Yantiss RK: MicroRNA eexpression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma. Pancreas 41:685-90, 2012.

Panarelli NC, Park KJ, Hruban RH, Klimstra DS: Microcystic serous cystadenoma of the pancreas with subtotal cystic degeneration: another neoplastic mimic of pancreatic pseudocyst. Am J Surg Pathol 36:726-31, 2012.

Jahid S, Sun J, Edwards RA, Dizon D, Panarelli NC, Sikandar SS, Gumus ZH, Lipkin SM: MiR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov 2:540-53, 2012.

Musa F, Huang M, Adams B, Pirog E, Holcomb K. Mucinous histology is a risk factor for nodal metastases in endometrial cancer. Gynecol Oncol. 2012 Jun;125(3):541-5.

Pirog EC. HPV as a pathogen of genital neoplasia and role of molecular markers in clinical diagnosis. Analyse 67(1):4-13, 2012.

Fadare O, Parkash V, Dupont WD, Acs G, Atkins KA, Irving JA, Pirog EC, Quade BJ, Quddus MR, Rabban JT 3rd, Vang R, Hecht JL. The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features. Am J Surg Pathol. 2012 Aug;36(8):1107-18.

Wang X, Prakash S, Lu M, Tripodi J, Ye F, Najfeld V, Li Y, Schwartz M, Weinberg R, Roda P, Orazi A, Hoffman R: Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest Oct 1 [Epub ahead of print], 2012.

Prakash S, Hoffman R, Barouk S, Wang YL, Knowles DM, Orazi A: Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition. Mod Pathol 5:815-27, 2012.

Di Bartolo DL, El Naggar M, Owen Renius, Sahoo T, Gilbert F, Pulijaal VR, Mathew S: Characterization of a complex rearrangement involving duplication and deletion of 9p in an infant with craniofacial dysmorphism and cardiac anomalies. Mol Cytogene 5: 31, 2012.

Ginsberg M, James D, Ding BS, Nolan D, Geng F, Butler JM, Schachterle W, Pulijaal VR, Mathew S, Chasen ST, Xiang J, Rosenwaks Z, Shido K, Elemento O, Rabbany SY, Rafii S: Efficient Direct Reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFb suppression. Cell 151:1, 2012.

Rennert H, Jenkins SG, Azurin C, Sipley J: Evaluation of a BK virus viral load assay using the QIAGEN artus® BK Virus RG PCR test. J Clin Virol 54:260-264, 2012.

Tan YC, Blumenfeld J, Michael A, Donahue S, Balina M, Parker T, Levine D, Rennert H: Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal dominant polycystic kidney disease. Clin Genet 80:287-292, 2011.

Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, Ostrander EA, Chanock S, Wang MH, Isaacs WB, Platz EA, Hayes RB: Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clin Can Res 17:1075-81, 2011.

Enan K, Rennert H, El-Eragi AM, El-Hussein AR, Elkhidir IM: Comparison of Real-time PCR to ELISA for the detection of human cytomegalovirus infection in renal transplant patients in the Sudan. Virology J 8:222-225, 2011.

Sipley J,Jenkins S, Carmen A, Rennert H: Evaluation of a BK virus viral load assay using the Qiagen artus® BK Virus RG PCR test. J Clin Virol 54:260-264, 2012.

Michaeel A, Donahue S, Parker T, Levine D, Jenkins S, Carmen A, Rennert H: Evaluation of a BK virus viral load assay using the Qiagen artus® BK Virus RG PCR test. J Clin Virol 54:260-264, 2012.

Tan YC, Blumenfeld J, Michaeel A, Donahue S, Parker T, Levine D, Rennert H: Development of a novel, and rapid genetic test for autosomal dominant polycystic kidney disease (ADPKD) genes, PKD1 and PKD2 using long-range PCR. J Mol Diag 14:305-313, 2012.

Tan YC, Blumenfeld J, Rennert H: Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs. Special issue on "Polycystic Kidney Disease", BBA - Molecular Basis of Disease. 1812:1202-1212, 2011 (Review).

Tan YC, Blumenfeld J, Rennert H: Autosomal dominant polycystic kidney disease. In Molecular Pathology In Clinical Practice (I. Scriver, ed.), p. 35-40, 2011.

Rennert H, Leonard DGB, Shore T: Bone marrow engraftment analysis in lineage specific CD3+ and CD33+ cells after double cord blood transplant. In Molecular Pathology In Clinical Practice (I. Schrijver, ed.), p. 147-157, 2011.

Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, NelsonJB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA: Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov 16:487-495. PMID: 22389870, 2011.

Demichelis F, Setlur, SR, Banerjee S, Chakravarty D, Yun J, Chen H, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan M, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H Rubin MA: Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. Proc Natl Acad Sci 109:6686-91, 2012.

Rickman DS, Soong TD, Moss B, Mosquera JM, Dlabal J, Terry S, MacDonald TY, Tripodi J, Bunting K, Najfeld V, Demichelis F, Melnick AM, Elemento O, Rubin MA: Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci USA. May 21. [Epub ahead of print], Highlighted in Nature, 2012.

Elemento O, Rubin MA, Rickman DS: Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer. Cell Cycle 11:3380-3, 2012. Epub Aug 23, 2012.

Giulino Roth L, Wang K, MacDonald TY, Mathew S, Tam Y, Cronin MT, Palmer G, Lucena-Silva N, Pedrosa F, Pedrosa M, Teruya-Feldstein J, Bhagat G, Alobeid B, Leoncini L, Bellan C, Rogena E, Pinkney KA, Rubin MA, Ribeiro RC, Yelensky R, Tam W, Stephens PJ, Cesarman E: Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes. Blood Oct 22 (Epub ahead of print)

Esgueva R, Park K, Kim R, Kitabayashi N, Barbieri CE, Dorsey PJ, Abraham C, Banerjee S, Leung RA, Tewari AK, Terry S, Shevchuk MM, Rickman DS, Rubin MA: Next generation prostate cancer biobanking: towards a processing protocol amenable for the International Cancer Genome Consortium. Diagn Mol Pathol 21:61-8, 2012.

Schreiner AM, Hoda RS: Herxheimer spiral on liquid-based Papanicolaou test. Diagn Cytopathol Sep 19. [Epub], 2011.

Schuetz AN, Pisapia D, Yan J, Hoda RS: An atypical histologic presentation of Coccidioides spp. in a lung fine needle aspirate. Diagn Cytopathol 40:163-7, 2012.

Weisenberg SA, Schuetz AN, Alexander EA, Eiss B, Behta M, Saiman L, Larone DH,Jenkins SG, Rhee KY: Endemic Acinetobacter baumannii in a New York hospital. PloS One 6:e28566, 2011.

Schuetz AN, Huard RC, Eshoo MW, Massire C, Della-Latta P, Wu F,Jenkins SG: Identification of a aovel acinetobacter baumannii Clone in a US hospital outbreak by multilocus PCR/Electrospray-Ionization mass spectrometry. Diagn Microbiol Infect Dis 72:14-19, 2012.

Keutgen XM, Filicori F, Crowley MJ, Wang Y, Scognamiglio T, Hoda R, et al: A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res 18:2032-8, 2012.

Narayan G, Freddy AJ, Xie D, Liyanage H, Clark L, Kisselev S, Kang JU, Nandula SV, McGuinn C, Subramaniyam S, Alobeid B, Satwani P, Savage D, Bhagat G, Murty VV: Promoter Methylation-Mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance. Genes Chro Can 50:1043-1053, 2011.

Boiocchi L, Espinal-Witter R, He B, Subramaniyam S, Mathew S, Nie K, Cerutti A, Coleman M, Knowles DM, Orazi A, Tam W: Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases. Am J Clin Pathol 137:647-659, 2012.

Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkær K, Chiu A, Tam W, Orazi A, et al: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP consortium program study. Leukemia 26:2103-13, 2012.

Lin J, Lwin T, Zhao JJ, Tam W, Choi YS, Moscinski LC, Dalton WS, Sotomayor EM, Wright KL, Tao J: Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin’s B-cell lymphomas. Leukemia 25:145-152, 2011.

Ballon G, Chen K, Perez R, Tam W, Cesarman E: Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J Clin Invest 121:1141-1153, 2011.

Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, Liu X, Bruno J, Heguy A, Olshen AB, Socci ND, Teruya-Feldstein J, Weis-Garcia F, Tam W, Shaknovich R, Melnick A, Himanen JP, Chaganti RSK, Wendel HG: The eph-receptor a7 is a soluble tumor suppressor for follicular lymphoma. Cell 147:554–564, 2011.

Cols M, Barra CM, He B, Puga I, Xu W, Chiu A, Tam W, Knowles DM, Dillon SR, Leonard JP, Furman RR, Chen K, Cerutti A: Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L. J Immunol 188:6071-6083, 2012.

Tam W: PRDM1 (PR domain containing 1, with ZNF domain). Atlas Genet Cytogenet Oncol Haematol 16:135-140, 2012

Wu Y, Tam, W: T-cell/histiocyte-rich large B cell lymphomas: a clinicopathologic distinct subtype of diffuse large B-cell lymphoma. Pathol Case Rev 17:52-56, 2012.

Cheng S, Coffey G, Zhang XH, Shaknovich R, Song Z, Lu P, Pandey A, Melnick AM, Sinha U, Wang YL: SYK inhibition and response prediction in diffuse large B-cell lymphoma. Blood 118, 6342-52, 2011.

Kuriakose E, Vandris K, Wang YL, Chow W, Jones AV, Christos PJ, Cross NCP, Silver RT: Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera. Haematologica. 97, 538-42, 2012.

Mackinnon AC, Wang YL, Sahota A, Yeung CC, Weck KE: Certification in molecular pathology in the United States: An update from the association for molecular pathology training and education committee. J Mol Diagn 14, 541-9, 2012.

Hannah J, Zhou P: Maximizing target protein ablation by integration of RNAi and protein knockout. Cell Res 21:1152-4. PMCID: PMC3129447, 2011.

Yin Y, Lin C, Kim S, Roi I, Chen H, Liu L, Veith G, Jin R, Keeney S, Jasin M, Moley K, Zhou P, Ma L: The E3 Ubiquitin Ligase Cullin 4A Regulates Meiotic Progression in Mouse Spermatogenesis. Dev Biol 356:51-6. PMCID: PMC3130830, 2011.

Cooper J, Li W, You L, Schiavon G, Pepe-Caprio A, Zhou L, Ishii R, Giovannini M, Hanemann CO, Long SB, Erdjument-Bromage H, Zhou P, Tempst P, Giancotti FG: Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression. Sci Signal 4, 6, 2011.

Liu L, Yan Y, Li Y, Prevedel L, Lacy EH, Ma L, Zhou P: Essential role of the CUL4B ubiquitin ligase in extraembryonic tissue development during mouse embryogenesis. Cell Res 22, 1258-1269. (Epub Mar 27. doi: 10.1038/cr.2012.48). PMCID: PMC3411166, 2012.

Lee J, Zhou P: Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front Oncol 2:21. doi: 10.3389/fonc.2012.00021, 2012.